Traitement Thymome en Israël — recevez 3 correspondances personnalisées de cliniques

Le Prof. Merimsky dirige l'unité d'oncologie des tissus mous et des os au centre médical Sourasky, avec plus de 25 ans d'expérience spécialisée dans le traitement du thymome.

• Formation spécialisée en sarcome à l'Institut Gustave Roussy à Paris
• Membre de la faculté des sarcomes de l'ESMO et du comité d'éthique de l'IASLC
• Pionnier de la recherche à l'Institut Weizmann et au centre médical Felsenstein
• Ancien président du département d'oncologie à la faculté de médecine Sackler

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Le Dr Ari Raphael dirige la recherche génomique sur le thymome au centre médical Sourasky, pionnier des techniques de biopsie liquide.

• Maître de conférences à la faculté de médecine de l'université de Tel Aviv
• Chercheur principal pour de multiples essais cliniques d'immunothérapie
• Modérateur du comité moléculaire des tumeurs pour la société israélienne du cancer du poumon
• Expert en profilage génomique complet des tumeurs thoraciques malignes

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.